Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 9, 2013, Pages 1527-1535

  Fuster, Daniel ^a   Tsui, Judith I ^a   Cheng, Debbie M ^a,b   Quinn, Emily K ^b   Bridden, Carly ^a   Nunes, David ^a   Libman, Howard ^c   Saitz, Richard ^a,b   Samet, Jeffrey H ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alcohol; Hepatitis C Virus; HIV; Liver Fibrosis

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; VIRUS RNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESPAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; THROMBOCYTE; VIRUS LOAD;

HEPATITIS C VIRUS;

ALCOHOL; HEPATITIS C VIRUS; HIV; LIVER FIBROSIS;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; COHORT STUDIES; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 84883223362     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12129     Document Type: Article

References (50)

1. Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436-2441.
2. Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, Wright T, VA-HCV-001 Study Group (2006) Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology 130:1607-1616.
3. Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG (2012) Assessing mortality in women with hepatitis C virus and human immunodeficiency virus using indirect markers of fibrosis. AIDS 26:599-607.
4. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Croce L, Sasso F, Pozzato G, Cristianini G, Brandi G (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41:845-850.
5. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-1058.
6. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492-497.
7. Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE (2011) HIV mono-infection is associated with FIB-4-a noninvasive index of liver fibrosis-in women. Clin Infect Dis 52:674-680.
8. Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA, STRIVE Project (2006) High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 81:259-265.
9. Castellano-Higuera A, Gonzalez-Reimers E, Aleman-Valls MR, Abreu-Gonzalez P, Santolaria-Fernandez F, De La Vega-Prieto MJ, Gomez-Sirvent JL, Pelazas-Gonzalez R (2008) Cytokines and lipid peroxidation in alcoholics with chronic hepatitis C virus infection. Alcohol Alcohol 43:137-142.
10. Chander G, Lau B, Moore RD (2006) Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 43:411-417.
11. Chaudhry AA, Sulkowski MS, Chander G, Moore RD (2009) Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort. HIV Med 10:133-142.
12. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
13. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB (2002) Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36:S161-S172.
14. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335-1374.
15. Hutchinson SJ, Bird SM, Goldberg DJ (2005) Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 3:1150-1159.
16. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K (2011) Increasing burden of liver disease in patients with HIV infection. Lancet 377:1198-1209.
17. Koenig LB, Jacob T, Haber JR (2009) Validity of the lifetime drinking history: a comparison of retrospective and prospective quantity-frequency measures. J Stud Alcohol Drugs 70:296-303.
18. Lieber CS, Weiss DG, Morgan TR, Paronetto F (2006) Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol 101:1500-1508.
19. Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D, Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA) (2008) Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol 103:1973-1980.
20. McCartney EM, Beard MR (2010) Impact of alcohol on hepatitis C virus replication and interferon signaling. World J Gastroenterol 16:1337-1343.
21. McCartney EM, Semendric L, Helbig KJ, Hinze S, Jones B, Weinman SA, Beard MR (2008) Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. J Infect Dis 198:1766-1775.
22. Mendeni M, Foca E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C (2011) Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. Clin Infect Dis 52:1164-1173.
23. Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL (2004) Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 39:826-834.
24. Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y, Munteanu M, Balian A, Njike-Nakseu M, Perlemuter G, Poynard T (2009) Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 49:97-105.
25. Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR Jr, Cotton D (2010) Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 105:1346-1353.
26. Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr (2005) HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 40:538-544.
27. Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Sorensen HT, Gerstoft J (2011) Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One 6:e22698.
28. Peters MG, Terrault NA (2002) Alcohol use and hepatitis C. Hepatology 36:S220-S225.
29. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832.
30. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL (2012) HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 205:1005-1013.
31. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M (2010) Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 29:437-445.
32. Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D (1997) Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6, 664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 26:485-490.
33. Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R (2007) Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 46:194-199.
34. Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A (2004a) Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res 28:572-577.
35. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA (2004b) Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses 20:151-155.
36. Sanvisens A, Fuster D, Serra I, Tor J, Tural C, Rey-Joly C, Muga R (2011) Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users. Curr HIV Res 9:256-262.
37. Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Guido M, Bourliere M, Noventa F, Alberti A (2009) SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 49:1821-1827.
38. Siu L, Foont J, Wands JR (2009) Hepatitis C virus and alcohol. Semin Liver Dis 29:188-199.
39. Skinner HA, Sheu WJ (1982) Reliability of alcohol use indices. The lifetime drinking history and the MAST. J Stud Alcohol 43:1157-1170.
40. Stein MD, Hanna L, Natarajan R, Clarke J, Marisi M, Sobota M, Rich J (2000) Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat 18:359-363.
41. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski SM, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M, APRICOT Clinical Investigators (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43:1317-1325.
42. Stoller EP, Hund AJ, Webster NJ, Blixen CE, Perzynski AT, McCormick RA, Kanuch SW, Dawson NV (2006) Alcohol consumption within the context of hepatitis C: a qualitative study of non-problematic drinkers. Alcohol Alcohol 41:546-552.
43. Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S (2006) Hepatitis C infection and alcohol use: a dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res 30:709-719.
44. Thein HH, Yi Q, Dore GJ, Krahn MD (2008) Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 22:1979-1991.
45. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 99:15661-15668.
46. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D (2000) The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284:450-456.
47. Tural C, Fuster D, Tor J, Ojanguren I, Sirera G, Ballesteros A, Lasanta JA, Planas R, Rey-Joly C, Clotet B (2003) Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients. J Viral Hepat 10:118-125.
48. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46:32-36.
49. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526.
50. Walley AY, Cheng DM, Libman H, Nunes D, Horsburgh CR Jr, Saitz R, Samet JH (2008) Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. AIDS 22:415-420.